Dehydroepiandrosterone (DHEA) PCD Pharma Franchise Company

Cafoli Lifecare offers a DHEA range of 5 formulations across softgels and tablets, manufactured in WHO-GMP certified facilities. Distributors serving fertility, gynaecology and reproductive-medicine prescribers can secure district-wise monopoly franchise rights with full promotional support.

What is Dehydroepiandrosterone (DHEA)?

Dehydroepiandrosterone (DHEA) is a naturally occurring steroid hormone produced by the adrenal glands that serves as a precursor to male and female sex hormones. Supplemental DHEA is used mainly to improve ovarian response and egg quality in women with diminished ovarian reserve undergoing fertility treatment. Reference: PubChem - Dehydroepiandrosterone.

Available Forms

The Cafoli DHEA portfolio includes Softgels and Tablets in the commonly used strengths (typically 25mg). Contact us for current pack presentations and combinations.

Therapeutic Applications

DHEA is used as an adjuvant in assisted reproduction to support ovarian reserve and egg quality in women with poor ovarian response, and in selected cases of DHEA deficiency. Prescribers are chiefly IVF and reproductive-medicine specialists and gynaecologists.

Why DHEA is a High-Potential Molecule for Distributors

The Indian IVF and fertility sector is growing rapidly, and DHEA supplementation has become a routine part of protocols for women with diminished ovarian reserve. As a specialist-driven, defined-course supplement with limited PCD competition, DHEA gives a distributor a differentiated, higher-value fertility line tied to the expanding assisted-reproduction market.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs.

References

1. PubChem: Dehydroepiandrosterone
2. MedlinePlus: DHEA
3. PubMed: DHEA and ovarian reserve in IVF